Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Kadcyla for adjuvant treatment in HER2-positive early breast cancer setting

May 6, 2019

AbbVie initiates phase III study of ABBV-951 in Parkinson's disease

May 6, 2019

Ramot at Tel Aviv University discloses compounds for neuropathic pain

May 6, 2019

Genentech and Roche present RIPK1 inhibitors

May 6, 2019

Syros Pharmaceuticals identifies new tyrosine-protein kinase inhibitors

May 6, 2019

First-in-human data presented for PBT-434 alpha-synuclein aggregation inhibitor

May 6, 2019

Preclinical data support development of AB-2004 for GI dysfunction in autism spectrum disorder

May 6, 2019

Prion may be answer to Alzheimer's amyloid riddle

May 6, 2019

TOP-1257, a potent inhibitor of inflammation and angiogenesis

May 6, 2019

KR-67607 shows potential as neuroprotective therapeutic agent for glaucoma

May 6, 2019

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...